Parasitologic Assessment of Two-Dose and Monthly Intermittent Preventive Treatment of Malaria during Pregnancy with Sulphadoxine-Pyrimethamine (IPTP-SP) in Lagos, Nigeria

Chimere O Agomo, Wellington A Oyibo, Funke Odukoya-Maije, Chimere O Agomo, Wellington A Oyibo, Funke Odukoya-Maije

Abstract

Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine (IPTP-SP) is a key strategy in the control of malaria in pregnancy. However, reports of increasing level of resistance to SP using nonpregnant populations have made it imperative for the continuous monitoring of the efficacy of SP in pregnant women. This study assessed using microscopy, monthly dosing and the standard two-dose regimen among 259 pregnant women attending antenatal clinics in Lagos, Nigeria that consented 122 in the two-dose arm (Arm A) and 137 in the monthly dose arm (Arm B). Baseline parasitaemia in the two groups was 5 (4.1%) and 3 (2.2%) in Arms A and B, respectively. Few of the women developed parasitaemia after the initial SP dose in Arms A 4 (3.3%) and B 2 (1.5%). However, none of the women had malaria infection after the second dose in both Arms. Although IPTP-SP is suggestive of protecting the women from malaria infection, there was no significant difference observed between the two dosing schemes.

Figures

Figure 1
Figure 1
Parasite clearance in the monthly and 2-dose IPTp-SP groups. Fisher Exact P = 0.625.

References

    1. World Health Organization. Tech. Rep. AFR/MAL/04/01. Brazzaville, Republic of Congo: WHO Regional Office for Africa; 2004. A strategic framework for malaria prevention and control during pregnancy in the African region.
    1. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science. 1996;272(5267):1502–1504.
    1. Hviid L, Salanti A. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria. Parasitology. 2007;134(13):1871–1876.
    1. Steketee R, Wirima J, Hightower A, Slutsker L, Heymann DL, Breman JG. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in Rural Malawi. American Journal of Tropical Medicine and Hygiene. 1996;55(1):33–41.
    1. Newman RD, Hailemariam A, Jimma D, et al. Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a nonepidemic year. Journal of Infectious Diseases. 2003;187(11):1765–1772.
    1. Rogerson SJ, Boeuf P. New approaches to pathogenesis of malaria in pregnancy. Parasitology. 2007;134(13):1883–1893.
    1. Federal Ministry of Health. Nigeria: Federal Ministry of Health; 2005. National guidelines and strategies for malaria prevention and control during pregnancy. Tech. Rep.
    1. White NJ. Intermittent presumptive treatment for malaria: a better understanding of the pharmacodynamics will guide more rational policymaking. PLoS Medicine. 2005;2:28–33.
    1. World Health Organization. WHO Technical Report Series. Geneva, Switzerland: World Health Organization; 1986. WHO expert committee on malaria. Eighteenth report.
    1. Nahlen BL, Alakija T, Ogunbode O, et al. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. The Lancet. 1989;2(8667):830–834.
    1. Sirima SB, Sawadogo R, Moran AC, et al. Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupela district, Burkina Faso. Clinical Infectious Diseases. 2003;36(11):1374–1382.
    1. Diallo M, Dabo CA, Saye R, et al. Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali. Medecine Tropicale. 2007;67(5):477–480.
    1. Kayentao K, Mungai M, Parise M, et al. Assessing malaria burden during pregnancy in Mali. Acta Tropica. 2007;102(2):106–112.
    1. Tukur IU, Thacher TD, Sagay AS, Madaki JK. A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women. American Journal of Tropical Medicine and Hygiene. 2007;76(6):1019–1023.
    1. Alkadi HO. Antimalarial drug toxicity: a review. Chemotherapy. 2007;53(6):385–391.
    1. Bzik DJ, Li WB, Horii T, Inselburg J. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proceedings of the National Academy of Sciences of the United States of America. 1987;84(23):8360–8364.
    1. Sibley CH, Hyde JE, Sims PF, et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology. 2001;17(12):582–588.
    1. Jones CR, Ovenell SM. Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects dosed with maloprim. Journal of Chromatography. 1979;163(2):179–185.
    1. Coleman MD, Mihaly GW, Edwards G, Howells RE, Breckenridge AM. The disposition of pyrimethamine base and pyrimethamine pamoate in the mouse: effect of route of administration. Biopharmaceutics and Drug Disposition. 1986;7(2):173–182.
    1. Edstein MD. Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man. Chemotherapy. 1987;33(4):229–233.
    1. Weidekamm E, Plozza-Nottebrock H, Forgo I, Dubach UC. Plasma concentrations of pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bulletin of the World Health Organization. 1982;60(1):115–122.
    1. Brentlinger PE, Behrens CB, Micek MA. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa. Lancet Infectious Diseases. 2006;6(2):100–111.
    1. Forna F, McConnell M, Kitabire FN, et al. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Reviews. 2006;8(1):24–36.
    1. Gimnig JE, MacArthur JR, M’bang’ombe M, et al. Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. American Journal of Tropical Medicine and Hygiene. 2006;74(5):738–743.
    1. Filler SJ, Kazembe P, Thigpen M, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. Journal of Infectious Diseases. 2006;194(3):286–293.
    1. Hamer DH, Mwanakasale V, MacLeod WB, et al. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. Journal of Infectious Diseases. 2007;196(11):1585–1594.
    1. Federal Ministry of Health. Federal Ministry of Health Nigeria. Nigeria: National Malaria and Vector Control Division Abuja; 2005. National antimalarial treatment policy.
    1. Agomo CO, Oyibo WA, Anorlu RI, Agomo PU. Prevalence of malaria in pregnant women in Lagos, South-West Nigeria. Korean Journal of Parasitology. 2009;47(2):179–183.
    1. World Health Organization. Preventing and Controlling Iron Deficiency Anaemia Through Primary Health Care. Geneva, Switzerland: WHO publications; 1989.
    1. Nyunt MM, Adam I, Kayentao K, et al. Pharmacokinetics of sulphadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clinical Pharmacology and Therapeutics. 2010;87(2):226–234.
    1. Mutabingwa TK, Muze K, Ord R, et al. Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania. PLoS ONE. 2009;4(4) Article ID e5138.
    1. Bloland P. WHO Monograph WHO/CDS/CSR/DRS/2001.4. Geneva, Switzerland: World Health Organization; 2001. Drug resistance in malaria.
    1. Kalanda G, Hill J, Verhoeff F, Brabin B. Comparative efficacy of chloroquine and sulphadoxine-pyrimethamine in pregnant women and children: a meta-analysis. Tropical Medicine and International Health. 2006;11(5):569–577.
    1. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene. 1998;59(5):813–822.
    1. van Eijk AM, Ayisi JG, ter Kuile FO, et al. Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Tropical Medicine and International Health. 2004;9(3):351–360.
    1. Gill CJ, MacLeod WB, Mwanakasale V, et al. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. Journal of Infectious Diseases. 2007;196(11):1577–1584.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다